Skip to main content
Tech.euFundingExplorerBeta

Dopavision

Dopavision is a therapeutic company developing a digital therapeutic for myopia.

Dopavision has raised €12M across 1 funding round from 3 investors, most recently a round in Jul 2021. Based in Berlin, Germany; active in Healthtech. Data as of 28 Oct 2026.

Berlin, Germanywww.dopavision.com ↗
Healthtech
← All companies
Total raised
€12M
€12,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2021-07
latest 2021-07

Funding by year

EUR raised per year
Dopavision — funding by year — interactive chart.
Data table
Dopavision — funding by year
2021€12M

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2021-07-14Other€12MBoehringer Ingelheim Venture Fund,Novartis Pharmaceuticals,Seventure PartnersView deal →

Investors

3
Boehringer Ingelheim Venture FundNovartis PharmaceuticalsSeventure Partners

Related news

Similar companies

same sector or country

Global coverage: FundingData